Co-Diagnostics (CODX) Earnings Date, Estimates & Call Transcripts

$1.28

+0.08 (+6.67%)

(As of 12:56 PM ET)

Upcoming Earnings Date: Nov. 14Estimated
Actual EPS (Aug. 8): -$0.25 Beat By $0.09
Consensus EPS (Aug. 8): -$0.34

CODX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CODX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Weiss Ratings

Who are Nvidia’s New Silent Partners?

Nvidia knows it can’t stand still as AI continues to grow at an exponential rate. That’s why CEO Jensen Huang consistently has his company ahead of the curve when it comes to artificial intelligence. Nvidia’s added $2 trillion in market cap in 2024.

I call these Nvidia’s “Silent Partners.”

Co-Diagnostics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	2	($0.21)	($0.20)	($0.21)
Q2 2024	2	($0.34)	($0.20)	($0.27)
Q3 2024	2	($0.33)	($0.14)	($0.24)
Q4 2024	2	($0.33)	($0.12)	($0.23)
FY 2024	8	($1.21)	($0.66)	($0.94)
Q1 2025	1	($0.33)	($0.33)	($0.33)
Q2 2025	1	($0.33)	($0.33)	($0.33)
Q3 2025	1	($0.27)	($0.27)	($0.27)
Q4 2025	1	($0.23)	($0.23)	($0.23)
FY 2025	4	($1.16)	($1.16)		($1.16)

CODX Earnings Date and Information

Co-Diagnostics last posted its quarterly earnings data on August 8th, 2024. The reported ($0.25) EPS for the quarter, topping analysts' consensus estimates of ($0.34) by $0.09. The business earned $2.66 million during the quarter, compared to analysts' expectations of $0.40 million. Co-Diagnostics has generated ($1.32) earnings per share over the last year (($1.32) diluted earnings per share). Earnings for Co-Diagnostics are expected to grow in the coming year, from ($1.23) to ($1.13) per share. Co-Diagnostics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.

Co-Diagnostics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/14/2024 (Estimated)	-	-	-	-	-	-	-
8/8/2024	Q2 2024	($0.34)	($0.25)	+$0.09	($0.25)	$0.40 million	$2.66 million
5/9/2024	Q1 2024	($0.21)	($0.31)	($0.10)	($0.31)	$3.10 million	$0.47 million
3/14/2024	Q4 2023	-	($0.50)	($0.50)	($0.50)	$3.63 million	$3.56 million
11/9/2023	Q3 2023	($0.29)	($0.20)	+$0.09	($0.20)	$0.20 million	$2.46 million
8/10/2023	Q2 2023	($0.24)	($0.31)	($0.07)	($0.31)	$0.75 million	$0.20 million
5/11/2023	Q1 2023	($0.23)	($0.20)	+$0.03	($0.20)	$1.10 million	$0.60 million
Trade Alongside Pelosi, Buffett, and More (Ad) People don't know that you can trade alongside politicians, lawmakers, and top investors like Warren Buffet, Bill Ackman, Steve Cohen and more. They also don’t know that they can learn how it’s done and receive daily, AI powered trade alerts for free! All because of one trading veteran that set up a free newsletter designed to level the playing field. Sign up takes less than 10 seconds, and you’ll start getting his alerts and market insights absolute
3/16/2023	Q4 2022	($0.15)	($0.32)	($0.17)	$0.04	$5.50 million	$1.40 million
11/10/2022	Q3 2022	($0.06)	($0.04)	+$0.02	($0.04)	$6.75 million	$5.09 million
8/11/2022	Q2 2022	$0.15	($0.10)	($0.25)	($0.12)	$20.50 million	$5.02 million
5/12/2022	Q1 2022	$0.18	$0.26	+$0.08	$0.18	$21.25 million	$22.70 million
3/24/2022	Q4 2021	$0.15	$0.25	+$0.10	$0.25	$21.50 million	$20.40 million
11/11/2021	Q3 2021	$0.21	$0.38	+$0.17	$0.38	$24.00 million	$30.10 million
8/12/2021	Q2 2021	$0.22	$0.33	+$0.11	$0.33	$21.00 million	$27.36 million
5/12/2021	Q1 2021	$0.22	$0.26	+$0.04	$0.26	$19.50 million	$20.03 million
3/24/2021	Q4 2020	$0.48	$0.45	($0.03)	$0.43	$26.73 million	$27.15 million
11/15/2020	Q3	$0.63	$0.53	($0.10)	$0.53	$28.00 million	$21.82 million
8/13/2020	Q2 2020	$0.59	$0.43	($0.16)	$0.43	$27.00 million	$24.04 million
5/14/2020	Q1 2020	($0.04)	($0.05)	($0.01)	($0.05)	$1.10 million	$1.55 million
3/31/2020	Q4	($0.09)	($0.09)	-	($0.10)	$0.15 million	$0.11 million
11/13/2019	Q3 2019	($0.08)	($0.10)	($0.02)	($0.10)	$0.10 million	$0.04 million

Co-Diagnostics Earnings - Frequently Asked Questions

When is Co-Diagnostics's earnings date?: Co-Diagnostics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on CODX's earnings history.
Did Co-Diagnostics beat their earnings estimates last quarter?: In the previous quarter, Co-Diagnostics (NASDAQ:CODX) reported ($0.25) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.34) by $0.09. Learn more on analysts' earnings estimate vs. CODX's actual earnings.
How much revenue does Co-Diagnostics generate each year?: Co-Diagnostics (NASDAQ:CODX) has a recorded annual revenue of $9.14 million.
How much profit does Co-Diagnostics generate each year?: Co-Diagnostics (NASDAQ:CODX) has a recorded net income of -$35.33 million. CODX has generated -$1.32 earnings per share over the last four quarters.
What is Co-Diagnostics's EPS forecast for next year?: Co-Diagnostics's earnings are expected to grow from ($1.23) per share to ($1.13) per share in the next year.